Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep and pain management after total knee replacement
ACTRN12615000413527Phase 4Recruiting
- Sponsor
- Oriql
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pregabalin, temazepam and amitriptyline in knee osteoarthritis (OA) (4 arms), sponsored by Oriql. Primary endpoints: Sleep quality, Neuropathic pain and 1 more. Started Jan 2016; status: recruiting.
02
Drugs
pregabalintemazepamamitriptyline
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12615000413527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000413527.